| Multiorgan and renal tropism of SARS-CoV-2 VG Puelles, M Lütgehetmann, MT Lindenmeyer, JP Sperhake, MN Wong, ... New England Journal of Medicine 383 (6), 590-592, 2020 | 2012 | 2020 |
| X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M DE MARCHI, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000 | 676 | 2000 |
| Intensive supportive care plus immunosuppression in IgA nephropathy T Rauen, F Eitner, C Fitzner, C Sommerer, M Zeier, B Otte, U Panzer, ... New England Journal of Medicine 373 (23), 2225-2236, 2015 | 674 | 2015 |
| X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted … JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 14 (10), 2603-2610, 2003 | 555 | 2003 |
| X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted … JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 14 (10), 2603-2610, 2003 | 555 | 2003 |
| Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy J Savige, M Gregory, O Gross, C Kashtan, J Ding, F Flinter Journal of the American Society of Nephrology 24 (3), 364-375, 2013 | 429 | 2013 |
| Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy O Gross, C Licht, HJ Anders, B Hoppe, B Beck, B Tönshoff, B Höcker, ... Kidney international 81 (5), 494-501, 2012 | 380 | 2012 |
| Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice V Ninichuk, O Gross, S Segerer, R Hoffmann, E Radomska, A Buchstaller, ... Kidney international 70 (1), 121-129, 2006 | 354 | 2006 |
| SARS-CoV-2 renal tropism associates with acute kidney injury F Braun, M Lütgehetmann, S Pfefferle, MN Wong, A Carsten, ... The Lancet 396 (10251), 597-598, 2020 | 347 | 2020 |
| Meta‐analysis of genotype–phenotype correlation in X‐linked Alport syndrome: impact on clinical counselling O Gross, KO Netzer, R Lambrecht, S Seibold, M Weber Nephrology Dialysis Transplantation 17 (7), 1218-1227, 2002 | 321 | 2002 |
| Alport syndrome—insights from basic and clinical research J Kruegel, D Rubel, O Gross Nature Reviews Nephrology 9 (3), 170-178, 2013 | 305 | 2013 |
| Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group CE Kashtan, J Ding, G Garosi, L Heidet, L Massella, K Nakanishi, K Nozu, ... Kidney international 93 (5), 1045-1051, 2018 | 302 | 2018 |
| Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome O Gross, B Beirowski, ML Koepke, J Kuck, M Reiner, K Addicks, N Smyth, ... Kidney international 63 (2), 438-446, 2003 | 279 | 2003 |
| Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD–related systemic inflammation K Andersen, MS Kesper, JA Marschner, L Konrad, M Ryu, SK Vr, ... Journal of the American society of nephrology 28 (1), 76-83, 2017 | 245 | 2017 |
| Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative CE Kashtan, J Ding, M Gregory, O Gross, L Heidet, B Knebelmann, ... Pediatric nephrology 28, 5-11, 2013 | 177 | 2013 |
| Expert consensus guidelines for the genetic diagnosis of Alport syndrome J Savige, F Ariani, F Mari, M Bruttini, A Renieri, O Gross, C Deltas, ... Pediatric Nephrology 34, 1175-1189, 2019 | 159 | 2019 |
| Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations J Temme, F Peters, K Lange, Y Pirson, L Heidet, R Torra, JP Grunfeld, ... Kidney international 81 (8), 779-783, 2012 | 156 | 2012 |
| COVID-19-associated nephritis: early warning for disease severity and complications? O Gross, O Moerer, M Weber, TB Huber, S Scheithauer The Lancet 395 (10236), e87-e88, 2020 | 147 | 2020 |
| Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease O Gross, R Girgert, B Beirowski, M Kretzler, HG Kang, J Kruegel, ... Matrix biology 29 (5), 346-356, 2010 | 147 | 2010 |
| Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis O Gross, E Schulze-Lohoff, ML Koepke, B Beirowski, K Addicks, W Bloch, ... Nephrology Dialysis Transplantation 19 (7), 1716-1723, 2004 | 134 | 2004 |
Hans-Joachim AndersLudwig Maximilians University Munich在 med.uni-muenchen.de 的电子邮件经过验证
